|Bid||364.80 x 0|
|Ask||365.20 x 0|
|Day's Range||359.50 - 365.10|
|52 Week Range||171.00 - 365.10|
|Beta (5Y Monthly)||0.47|
|PE Ratio (TTM)||27.53|
|Forward Dividend & Yield||3.00 (0.95%)|
|Ex-Dividend Date||Apr 21, 2021|
|1y Target Est||87.86|
Getinge, a leading global provider of products and solutions that contribute to quality enhancement and cost efficiency within healthcare and life sciences, now introduces Torin with AI in the United States. The company also announced results from a landmark survey of hospital executives and surgeons in the U.S. showing hospitals are taking steps to speed up OR turnover times, hire new staff and require staff to work longer hours to address backlogs.
Getinge has launched a new framework for social financing and a new social bond of SEK 570 million. The capital will be used to expand the production capacity of products that save lives.
Today, Getinge announces clearance from the US FDA of several new software options for the Servo-u and Servo-n ventilators. In addition to the latest software upgrades, Getinge also received clearance for the new Servo-u MR ventilator for the MRI room.